Advanced Biomed Inc. (NASDAQ: ADVB) announced a definitive agreement with Helena Global Investment Opportunities I Ltd. on Friday.The agreement allows Advanced Biomed to issue and sell up to $25 ...

Since it was founded in 1941, Texas Biomedical Research Institute has been shrouded in lore — a sprawling and unique campus on the cutting edge of infectious disease research founded by an ...

Researchers at Rochester Institute of Technology developed new artificial intelligence techniques to extract and visualize information from standard-of-care biomedical data, providing a means for ...

The trial is the result of a partnership between Rejuvenate Biomed, the University of Leicester, the National Institute for Health and Care Research (NIHR) Leicester Biomedical Research Centre (BRC), ...

Texas Gov. Greg Abbott announced that NtxBio, a health care biomanufacturing company, is building a new facility in Plano. The $31 million facility will reportedly create 170 jobs assembling ...

BERKELEY, US and MAINZ, Germany – April 29, 2025 – Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of ...

Mainz Biomed N.V., a molecular genetics diagnostic company, announced significant achievements in the first quarter of 2025 and provided an update on its progress toward FDA premarket approval.

The potential diversion of government funds for biomedical research has sparked intense debate in recent weeks. Understandably, many in the medical and scientific communities are concerned about ...

BioMed Realty has made a big long-term bet on demand in San Diego’s life science sector with a $255M acquisition of Pfizer’s sprawling research campus in the city. The five-building office ...

Mainz Biomed and Thermo Fisher Scientific signed a collaboration agreement for the development of the Company’s next generation colorectal cancer (CRC) screening product for global markets.

BERKELEY, US – MAINZ, Germany – March 27, 2025 — Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of ...

Shares of Harbour BioMed soared after the Chinese biopharmaceutical firm announced a collaboration with U.K. pharma giant AstraZeneca, which plans to invest $2.5 billion in China. The stock rose ...